SARS-CoV-2 spike protein promotes inflammatory cytokine activation
By A Mystery Man Writer
Description
Background Coronavirus disease 2019 (COVID-19) induces inflammation, autoantibody production, and thrombosis, which are common symptoms of autoimmune diseases, including rheumatoid arthritis (RA). However, the effect of COVID-19 on autoimmune disease is not yet fully understood. Methods This study was performed to investigate the effects of COVID-19 on the development and progression of RA using a collagen-induced arthritis (CIA) animal model. Human fibroblast-like synoviocytes (FLS) were transduced with lentivirus carrying the SARS-CoV-2 spike protein gene in vitro, and the levels of inflammatory cytokine and chemokine expression were measured. For in vivo experiments, CIA mice were injected with the gene encoding SARS-CoV-2 spike protein, and disease severity, levels of autoantibodies, thrombotic factors, and inflammatory cytokine and chemokine expression were assessed. In the in vitro experiments, the levels of inflammatory cytokine and chemokine expression were significantly increased by overexpression of SARS-CoV-2 spike protein in human FLS. Results The incidence and severity of RA in CIA mice were slightly increased by SARS-CoV-2 spike protein in vivo. In addition, the levels of autoantibodies and thrombotic factors, such as anti-CXC chemokine ligand 4 (CXCL4, also called PF4) antibodies and anti-phospholipid antibodies were significantly increased by SARS-CoV-2 spike protein. Furthermore, tissue destruction and inflammatory cytokine level in joint tissue were markedly increased in CIA mice by SARS-CoV-2 spike protein. Conclusions The results of the present study suggested that COVID-19 accelerates the development and progression of RA by increasing inflammation, autoantibody production, and thrombosis. Video Abstract
SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime
Machine learning identifies molecular regulators and therapeutics for targeting SARS‐CoV2‐induced cytokine release
Mechanisms for the nonantibiotic activities of minocycline and
Biology, Free Full-Text
Frontiers Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors
The COVID-19 pandemic: an increased risk of rheumatoid arthritis
Phenotype scoring of CIA in M. fascicularis. a Significant changes
SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders
Why does COVID-19 disproportionately affect older people?
Frontiers Multifaceted role of SARS-CoV-2 structural proteins in
CD4 Monoclonal Antibody (RM4-5), PE-eFluor™ 610 (61-0042-82)
from
per adult (price varies by group size)